Historic Price Milestone
On 08 June 2026, Integrated Proteins Ltd’s stock price closed at ₹140.00, surpassing its previous 52-week high of ₹139.65 by a narrow margin of 0.25%. This marks the highest valuation the stock has ever attained, reflecting sustained investor confidence and strong market positioning within the edible oil industry. The stock’s performance today showed a positive day change of 1.82%, contrasting with the broader Sensex index which declined by 0.95% on the same day.
Price Movement and Trading Range
Despite opening with a gap down of 2% at ₹134.75 and touching an intraday low at the same level, the stock managed to recover and close at its peak price. The trading range was relatively narrow, with the stock maintaining its price around the opening level before rallying to the closing high. This price action indicates a resilient demand for the stock amid sectoral pressures, as the solvent extraction segment experienced a decline of 2.15% on the day.
Technical Indicators and Trend Analysis
The technical outlook for Integrated Proteins Ltd remains bullish, supported by multiple indicators. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, although it remains slightly below the 5-day moving average. Key technical signals such as MACD, Bollinger Bands, KST, and Dow Theory all indicate a positive momentum on both weekly and monthly timeframes. The current bullish trend was established on 27 March 2026 when the stock price was ₹71.33, highlighting a strong upward trajectory over the past few months.
Long-Term Performance Outshines Benchmarks
Integrated Proteins Ltd has demonstrated exceptional long-term growth relative to the Sensex benchmark. Over the past year, the stock has surged by 216.03%, while the Sensex declined by 10.52%. Year-to-date performance is even more striking, with a gain of 306.98% compared to the Sensex’s 13.71% fall. Over a three-year horizon, the stock has appreciated by an extraordinary 1,295.81%, dwarfing the Sensex’s 17.01% gain. The ten-year performance is particularly notable, with a staggering 6,442.06% increase, far exceeding the Sensex’s 172.17% rise. These figures underscore the company’s ability to deliver substantial shareholder value over extended periods.
Valuation Metrics Reflect Premium Pricing
The stock currently trades at a price-to-earnings (P/E) ratio of 525 times trailing twelve months earnings, indicating a premium valuation consistent with high growth expectations. Other valuation multiples include a price-to-book value (P/BV) of 12.53 times and an enterprise value to EBITDA (EV/EBITDA) ratio of 257.33 times. The enterprise value to sales ratio stands at 26.02 times, reflecting the market’s willingness to pay a premium for the company’s revenue base. Despite these elevated multiples, the stock’s valuation is supported by its strong price momentum and market leadership within the edible oil sector.
Quality and Financial Trends
Integrated Proteins Ltd holds an average quality grade, with a balanced financial profile. The company has achieved a five-year sales compound annual growth rate (CAGR) of 61.22%, demonstrating robust top-line expansion. However, earnings before interest and tax (EBIT) growth over the same period has been more modest at 6.65%. The company maintains a strong capital structure with negligible debt, reflected in an average debt to EBITDA ratio of 0.46 and zero net debt to equity. The return on capital employed (ROCE) and return on equity (ROE) are relatively weak at -4.21% and 2.06% respectively, indicating room for improvement in profitability metrics.
Recent Financial Performance
In the short term, the company’s profit after tax (PAT) for the nine months ending March 2026 was ₹0.26 crores, showing an increase compared to previous periods. However, net sales for the latest six months declined by 73.53% to ₹5.69 crores, signalling a contraction in revenue during this timeframe. Despite this, the stock’s price performance and technical strength have remained resilient, supported by long-term growth prospects and market sentiment.
Market Capitalisation and Grade Update
Integrated Proteins Ltd is classified as a micro-cap company, reflecting its relatively modest market capitalisation. The company’s Mojo Score stands at 58.0, with a current Mojo Grade of ‘Hold’, upgraded from ‘Sell’ on 29 May 2026. This upgrade reflects an improved assessment of the company’s fundamentals and market position by MarketsMOJO, the analytics platform providing these ratings.
Delivery Volumes and Trading Activity
Recent trading activity shows a significant increase in delivery volumes, with a 64.82% rise in one-day delivery compared to the five-day average. Over the trailing one-month period, delivery volumes increased by 51.47%, indicating heightened investor participation in the stock. These trends support the stock’s sustained price appreciation and all-time high achievement.
Summary of Key Technical Levels
The stock’s immediate support level is at ₹20.71, corresponding to its 52-week low, while immediate resistance was previously noted at ₹129.88, near the 20-day moving average. The recent breakthrough past the 52-week high of ₹139.65 establishes a new major resistance level, setting a fresh benchmark for the stock’s price trajectory.
Conclusion
Integrated Proteins Ltd’s attainment of an all-time high price of ₹140.00 on 08 June 2026 marks a significant milestone in its market journey. Supported by strong long-term growth, a bullish technical trend, and improved market sentiment reflected in its upgraded Mojo Grade, the company has demonstrated resilience and strength within the edible oil sector. While valuation multiples remain elevated and short-term sales have contracted, the stock’s performance relative to broader market indices and sector peers highlights its distinctive market position and investor appeal.
